Comment on &quot;Impact of a Novel Electronic Monitor on Psoriasis Patient Adherence to Prescribed Dose Frequency and Amount&quot;.

Sotyktu (deucravacitinib) - BMS

Comment on "Impact of a Novel Electronic Monitor on Psoriasis Patient Adherence to Prescribed Dose Frequency and Amount". (PubMed, J Am Acad Dermatol) - Sep 13, 2026 - No abstract available
Journal • Dermatology • Immunology • Psoriasis

http://www.ncbi.nlm.nih.gov/pubmed/42731702

Hanlu Li

Sep 13, 2026